MyDNA

myDNA is a world leader in precision health, delivering clinically validated DNA insights to support healthcare providers, laboratories, and health systems. Our solutions enable personalised prescribing, risk stratification, and preventative care, advancing healthcare from reactive to proactive. Through continuous innovation, we support the global shift toward data-driven, individualised healthcare.

We empower healthcare practitioners with evidence-based insights to support precision medicine.
Our pharmacogenomic reports help optimise prescribing across mental health, cardiovascular, gastroenterology, pain, and oncology. Working with leading pathology labs, hospitals, and pharmacies, myDNA delivers clinical testing and reporting at scale.

Our product portfolio also includes nutrigenomics for personalised nutrition and fitness, as well as hereditary risk screening for conditions such as cancer, cardiovascular disease, and neurodegenerative disorders.

myDNA success is driven by a dedicated team of pharmacogenomic specialists, including clinical geneticists, clinical pharmacologists, bioinformaticians, and pharmacists. This expertise allows them to provide leading pharmacogenomic reporting solutions to laboratories across the globe.